Cellebrite DI lowers FY2026 sales guidance range to $555M-$561M
Cellebrite DI cuts its FY2026 sales outlook to $555.000 million-$561.000 million from $565.000 million-$571.000 million, versus a $568.048 million estimate.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.